APOL1-mediated Kidney Disease Clinical Trials in Durham, North Carolina
2 recruitingDurham, North Carolina
Showing 1–2 of 2 trials
Recruiting
Phase 2
Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease
APOL1-mediated Kidney Disease
AstraZeneca96 enrolled77 locationsNCT06824987
Recruiting
Not Applicable
APOL1 Genotyping CTA Clinical Performance Study
APOL1-mediated Kidney Disease
Almac Diagnostic Services LLC1,000 enrolled1 locationNCT06839833